Skip to main content
Clinical Trials/NCT05483036
NCT05483036
Completed
Not Applicable

Perception in Parkinson's Disease

Boston University Charles River Campus1 site in 1 country54 target enrollmentSeptember 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson's Disease
Sponsor
Boston University Charles River Campus
Enrollment
54
Locations
1
Primary Endpoint
Parkinson's Anxiety Scale (PAS)
Status
Completed
Last Updated
7 months ago

Overview

Brief Summary

The investigators plan to examine the relation of perceptual variables-basic vision, unusual perceptual experiences(including but not limited to visual hallucinations)-to relevant functional variables such as cognition, mood, and alertness/sleepiness in an online sample of persons with Parkinson's disease (PwPD). It is hypothesized that unusual perceptual experiences will relate significantly to the selected variables. Participants do not need to experience visual hallucinations to be able to participate in this study. This is an observational study only, and not an interventional study.

Detailed Description

For this study, the investigators propose to conduct an online study of PwPD (proposing a total of 60 participants) to examine the relations among variables that may relate to perception in PD. Those PwPD who express interest will be sent a link to an online survey (Qualtrics). The investigators will collect demographic and health information, followed by questionnaires assessing unusual perceptual experiences, mood, motivation, sleep, fatigue and quality of life. The survey should take roughly 45 minutes to an hour to complete. Compensation: A $20 Amazon gift card will be offered to those who complete the survey all the way through with good effort.

Registry
clinicaltrials.gov
Start Date
September 1, 2022
End Date
May 1, 2025
Last Updated
7 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Boston University Charles River Campus
Responsible Party
Principal Investigator
Principal Investigator

Alice Cronin-Golomb

Director, Vision and Cognition Laboratory

Boston University Charles River Campus

Eligibility Criteria

Inclusion Criteria

  • Participants must be at least 40 years old
  • Have a self-reported diagnosis of idiopathic PD
  • Be proficient English speakers
  • Have functional vision
  • Have internet access, and access to a desktop computer or laptop

Exclusion Criteria

  • Self-reported poor vision (non-functional range)
  • Lack of access to internet and either a desktop computer or laptop

Outcomes

Primary Outcomes

Parkinson's Anxiety Scale (PAS)

Time Frame: Baseline

Assesses the severity of anxiety symptoms in persons with Parkinson's disease. Maximum score:48. Higher scores indicate more severe anxiety.

Penn Online Evaluation of Migraine (POEM)

Time Frame: Baseline

Assesses headaches and migraine-related history.

Noise Pareidolia Test

Time Frame: Baseline

Assesses tendency to see meaningful objects such as faces, animals, and objects in ambiguous patterns. Higher scores (on items with no face) indicate a higher number of pareidolic responses.

Center for Epidemiological Studies Depression Scale (CES-D)

Time Frame: Baseline

Assesses depressive symptoms in the general population. Maximum score:60. Higher scores indicate more severe depression.

NIH NeuroQoL measures

Time Frame: Baseline

Assesses health-related quality of life in adults with neurological disorders. Higher scores on the sub-scales indicate worse outcomes.

Mooney Faces

Time Frame: Baseline

Assesses the ability to see an upright, inverted, or scrambled face in a black and white pattern. Higher scores (on items with no face) indicate a higher number of pareidolic responses.

BU Hallucinations and Unusual Perceptual Experiences questionnaire (BU-HUPE)

Time Frame: Baseline

Assesses different types of visual hallucinations - simple VH; illusions; minor hallucinations: vivid sense of presence or movement in periphery (passage); and complex VH (e.g., people, animals, objects), as well as temporal and descriptive characteristics of the hallucinations. Higher scores indicate more unusual perceptual experiences.

Prodromal Questionnaire, Brief Version (PQ-B)

Time Frame: Baseline

Assesses risk for psychosis by asking about positive symptoms and related distress/impairment. Higher scores indicate higher risk for psychosis and higher related distress.

Parkinson's Disease - Psychotic Symptoms Scale (PD-PSS)

Time Frame: Baseline

Assesses the frequency and severity of minor hallucinations (passage hallucinations, presence hallucinations, visual illusions), and structured hallucinations in PD. Higher scores indicate higher frequency of psychotic symptoms.

Epworth Sleepiness Scale (ESS)

Time Frame: Baseline

Assesses a person's general level of daytime sleepiness. Maximum Score: 24. Higher scores indicate a higher chance of dozing.

Parkinson's Disease Sleep Scale-2

Time Frame: Baseline

Assesses sleep and nocturnal disturbances in Parkinson's disease. Maximum score: 60. Higher scores indicate more frequent sleep disturbances.

Parkinson's Disease Questionnaire - 39 (PDQ-39)

Time Frame: Baseline

Assesses Parkinson's disease-specific health-related quality of life. Higher scores indicate worse quality of life.

Non-Motor Symptoms Questionnaire (NMSQ)

Time Frame: Baseline

Assesses a range of non-motor symptoms in Parkinson's disease. Higher scores indicate the presence of more non-motor symptoms.

The Movement Disorders Society Unified Parkinson Disease Rating Scale (MDS-UPDRS)

Time Frame: Baseline

Assesses motor and non-motor experiences of daily living in Parkinson's disease. Higher scores indicate increased severity of motor and non-motor symptoms.

Study Sites (1)

Loading locations...

Similar Trials